WASHINGTON--(BUSINESS WIRE)--Presented today at the Cardiovascular Research Foundation’s annual TCT meeting, a pooled analysis of safety data from Medtronic’s ENDEAVOR clinical program affirmed the superior safety of the Endeavor® drug-eluting coronary stent compared to the best-in-class Medtronic bare metal stent, Driver®.
